I would personally be doing jumping jacks and jazz hands to only pay $100 a month. Try Seti on for size.......100 per month would make it unaffordable for many
I would personally be doing jumping jacks and jazz hands to only pay $100 a month. Try Seti on for size.......100 per month would make it unaffordable for many
what I'm more concerned about right now is availability on markets outside of the US like Europe since in their presentation they are only talking about application to FDA but not their european counterparts which it would also need to go through tho. so if things turn out sh*t, this might be on the market in the US in 2022 but for Europeans it is still up for testing for maybe years which is a time frame that would completely ruin my hair. f*****g bullshit. same with winlevi, they don't even talk about european approval
This
FDA is often considered as a world standard though. I may be wrong
Would it be difficult to get it to Europe when only approved in US?Found this on their website:
http://www.cassiopea.com/company/strategy.aspxView attachment 111992
So, it seems like they intend to focus on the US market at first It definitely is a bit weird to me considering they are an European company and do their trial in Germany, but they are a small company and it seems like they don‘t have enough capabilities to enter more than one market at a time. And for them the US market is the most homogeneous market to enter.
So probably they are looking for a bigger European pharma company as partner after their Winlevi launch in the US, that takes care of the EMA approval. Maybe it‘s going to be cosmo, their parent company. And maybe once they have their partner after Winlevi, that partner intends to launch Breezula at the same time as in the US. I dont think they will lose too much time, as the European market is the potentially bigger market.
Would it be difficult to get it to Europe when only approved in US?
Yes you are right, but they still need an EMA approval to market it in the EU, and that takes as long as the FDA approval process.
But if everything goes wrong, 2022 seems like a good year to spend the holidays in the United States.
None of this pricing stuff has been decided
The acne cream Will be out next year so we can use this until breezula and in many countries acne products are subsidized by health insurances so maybe it's time to befriend some young kids with acne
putting cream in our hair.. my hair are already so greasy i cant imagine putting cream on it and go outsite
Since this is a purportedly side effects free drug, hopefully it could be approved without controversy.
I believe we should look at how and when Propecia and Rogaine were approved by EU regulators to have an idea of what might happen with Breezula, actually, hold on - isn't Cassiopea an Italian company?
I'm confused now
Or maybe you are a student, you have another disease have lost your job, live in a poor country or are in situations beyond your control - just like male pattern baldness. I believe none of us would like to be called a loser for something whoch is beyond our control
Not sure EMA would even approve this sketchy sh*tChill out Euro guys. You just had exclusive access to Trinov, now its our turn.
their stock is doing very badly. probably because they mentioned how they require much more money from investors in the future... but -7% is pretty bad. hopefully they won't run out of money. also in their presentation they didn't mention anymore how the expect to be the 12 month data to be even more effective than what they saw after 6 months-they did mention this in their presentation last year. not a good idea to interpret too much into this but I wouldn't be surprised-with the luck that we normally have since decades- if 12 month results are actually less effective than 6 month data, that people started to lose hair again
Guys chill...
If you run trials for the FDA then you don't need to redo them for EMA. Usually most companies apply for approval at the same time for both the FDA and EMA and approval comes more or less at the same time on average. So don't worry about that.
Also did someone by chance listen to their call?
The stock going down is probably because there was basically no news at all in the annual report... I am sure it will go up when they announce results of trials...
I don't know.. maybe because it works from a different angle directly at the receptor, maybe the receptor gets more sensitive when it finds out it is being inhibited. but by that logic finasteride would have to lose efficiency very quickly as well.. also then this probably would have happened with winlevi as well but there 12 months was great. so the principle of it obviously works for a longer time. I don't know, I just thought we would find out some really good sh*t today but I guess it's not that grim at this point
Anybody in the UK or London that knows how to get CB from Kane shop? Willing to do a group buy